Related Experiment Video
Updated: May 11, 2026
Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron
Published on: February 23, 2024
Chelation of chromium(VI) by combining deferasirox and deferiprone in rats
Marzieh Iranmanesh1, S Jamil A Fatemi, Roza Ebrahimpour
1Chemistry Department, Shahid Bahonar University of Kerman, 22 Bahman Blvd, PO BOX 76961, Kerman, Iran. mzh_iranmanesh@yahoo.com
Abstract:
The present research is aimed to characterize the potential efficiency of two chelators after chromium(VI) administration for 60 days following two doses of 15 and 30 mg/kg chromium(VI) per body weight daily to male rats. However, the hypothesis that the two chelators might be more efficient as combined therapy than as single therapy in removing chromium(VI) from rat organs was considered. In this way, two known chelators deferasirox and deferiprone were chosen and given orally as a single or combined therapy for a period of 1 week. Chromium(VI) and iron concentrations in tissues were determined by flame atomic absorption spectroscopy. The combined chelation therapy results show that deferasirox and deferiprone are able to remove chromium(VI) ions from various tissues while iron concentration returned to normal levels and symptoms also decreased.
Related Concept Videos
00:56Extraction: Advanced Methods
01:19Complexation Equilibria: The Chelate Effect
01:26Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...